There is a significant unmet medical need for antidepressants that are effective, rapid onset of action and to be well tolerated
The program will offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
The global TCIM market is expected to reach nearly US$ 600 billion by 2025
Capricor’s BLA for Deramiocel received Priority Review in March 2025
Celecoxib is a nonsteroidal anti-inflammatory drug
GII is a leading investment firm with assets under management exceeding US$ 3.5 billion with presence across Saudi Arabia, UAE, Europe, USA and India
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
Ukhade brings deep expertise in large-scale infrastructure planning, cross-functional leadership, and project innovation.
Subscribe To Our Newsletter & Stay Updated
